JP2006316075A5 - - Google Patents

Download PDF

Info

Publication number
JP2006316075A5
JP2006316075A5 JP2006239375A JP2006239375A JP2006316075A5 JP 2006316075 A5 JP2006316075 A5 JP 2006316075A5 JP 2006239375 A JP2006239375 A JP 2006239375A JP 2006239375 A JP2006239375 A JP 2006239375A JP 2006316075 A5 JP2006316075 A5 JP 2006316075A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
solution
range
concentration
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006239375A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006316075A (ja
JP4820244B2 (ja
Filing date
Publication date
Priority claimed from US09/255,513 external-priority patent/US6207661B1/en
Application filed filed Critical
Publication of JP2006316075A publication Critical patent/JP2006316075A/ja
Publication of JP2006316075A5 publication Critical patent/JP2006316075A5/ja
Application granted granted Critical
Publication of JP4820244B2 publication Critical patent/JP4820244B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006239375A 1999-02-22 2006-09-04 ピペラジンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物 Expired - Lifetime JP4820244B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/255,513 US6207661B1 (en) 1999-02-22 1999-02-22 Premixed formulation of piperacillin sodium and tazobactam sodium injection
US09/255,513 1999-02-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000600646A Division JP2002537335A (ja) 1999-02-22 2000-01-21 ピペラシリンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物

Publications (3)

Publication Number Publication Date
JP2006316075A JP2006316075A (ja) 2006-11-24
JP2006316075A5 true JP2006316075A5 (https=) 2009-12-10
JP4820244B2 JP4820244B2 (ja) 2011-11-24

Family

ID=22968672

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000600646A Withdrawn JP2002537335A (ja) 1999-02-22 2000-01-21 ピペラシリンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物
JP2006239375A Expired - Lifetime JP4820244B2 (ja) 1999-02-22 2006-09-04 ピペラジンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000600646A Withdrawn JP2002537335A (ja) 1999-02-22 2000-01-21 ピペラシリンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物

Country Status (12)

Country Link
US (1) US6207661B1 (https=)
EP (1) EP1154770B1 (https=)
JP (2) JP2002537335A (https=)
AT (1) ATE426404T1 (https=)
AU (1) AU2856200A (https=)
CA (1) CA2361392C (https=)
CY (1) CY1108966T1 (https=)
DE (1) DE60041868D1 (https=)
DK (1) DK1154770T3 (https=)
ES (1) ES2322790T3 (https=)
PT (1) PT1154770E (https=)
WO (1) WO2000050035A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011718A1 (it) * 2001-08-03 2003-02-03 Istituto Biochimico Italiano Processo per la preparazione del sale sodico dell'acido-6(d-(-)-alpha-(4-etil-2,3-diosso-1-piperazinocarbonilammino)fenilacetammido)penicill
EP1468697B1 (en) * 2003-04-14 2007-12-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection
US6900184B2 (en) * 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection
WO2004098643A1 (en) * 2003-04-14 2004-11-18 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection
KR20070110256A (ko) * 2004-10-14 2007-11-16 와이어쓰 유산나트륨 희석제 내에 피페라실린, 타조박탐 및아미노카르복실산을 함유하는 조성물
ES2284318B1 (es) * 2005-04-13 2008-11-01 Labiana Development, S.L. Procedimiento de obtencion de una mezcla en polvo de una sal sodica de piperaciclina y tazobactama, util para su administracion por via inyectable.
EP1787641A1 (de) * 2005-11-22 2007-05-23 Helm AG Tazobactam-Piperacillin-Lyophilisat
US20070286817A1 (en) * 2006-06-07 2007-12-13 Wyeth Treating cystic fibrosis with antibiotics via a swirler delivery
US20070286818A1 (en) * 2006-06-07 2007-12-13 Wyeth Treating cystic fibrosis with antibiotics via an aerosol drug
CN1927201B (zh) * 2006-08-25 2011-06-01 天津和美生物技术有限公司 含哌拉西林的抗生素复方
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN110279698B (zh) 2013-03-15 2022-10-28 默沙东有限责任公司 头孢特咯瓒抗生素组合物
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103550216B (zh) * 2013-10-30 2015-03-11 济南康和医药科技有限公司 一种哌拉西林钠他唑巴坦钠药物组合物及其制备方法
AU2016223619A1 (en) * 2015-02-23 2017-08-10 Sandoz Ag Penicillin retard composition for intramuscular injection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2179348A5 (https=) 1972-04-06 1973-11-16 Berthoud Sa
US4452778A (en) 1980-03-31 1984-06-05 Eli Lilly And Company Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms
CA1209477A (en) 1981-03-26 1986-08-12 Bruce E. Haeger Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4477452A (en) 1981-03-26 1984-10-16 American Cyanamid Company Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4534977A (en) 1981-03-26 1985-08-13 American Cyanamid Company Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US4552763A (en) 1981-12-21 1985-11-12 Eli Lilly And Company Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms
US4594247A (en) 1981-12-21 1986-06-10 Eli Lilly And Company Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms
US4562073A (en) 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
US4535078A (en) 1984-04-06 1985-08-13 The Trustees Of Columbia University In The City Of New York Antibacterial composition comprising silver sulfadiazine and sodium piperacillin
BG46664A1 (en) * 1985-08-16 1990-02-15 Druzhestven N Izsledovatelski Method for preparing of 6- /d (-)- alpha- (4- ethyl- 2, 3- dioxo- 1- piperazine carbonylamino)- phenylacetamido/- penicillanic acid
IT1213352B (it) 1986-10-06 1989-12-20 Valleambrosia Di Rozzano Milan Procedimento per la preparazione dell'acido 6-[d(-)-alfa-(4-etil-2,3-diossipiperazin-1-ilcarbonilamino)-alfa-fenilace tamido]penicillanico e intermedi utili in detto procedimento.
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
US5358853A (en) 1992-08-03 1994-10-25 Akzo Av Liquid thromboplastin reagent
EP0678095A1 (en) 1993-11-06 1995-10-25 Taiho Pharmaceutical Co., Ltd. Crystalline penicillin derivative, and its production and use
JPH0859471A (ja) * 1994-08-25 1996-03-05 Taiho Yakuhin Kogyo Kk 抗マラリア剤
JPH0867638A (ja) * 1994-08-31 1996-03-12 Nikken Chem Co Ltd エリスリトール含有注射剤
US5650421A (en) 1995-03-31 1997-07-22 Baxter International Inc. Premixed famotidine formulation
JPH1050800A (ja) * 1996-08-05 1998-02-20 Canon Sales Co Inc 処理装置
JPH10168091A (ja) * 1996-12-12 1998-06-23 Ss Pharmaceut Co Ltd ジアミン白金錯体及びこれを含有する医薬

Similar Documents

Publication Publication Date Title
JP2006316075A5 (https=)
JP2002537335A5 (https=)
JP2019131596A5 (https=)
CN104812392B (zh) 稳定的培美曲塞制剂
JP2012530770A5 (https=)
RU2016122609A (ru) Составы соединений азаиндола
AR098013A2 (es) UNA COMPOSICIÓN FARMACÉUTICA ACUOSA ESTÉRIL, LISTA PARA SU USO, ADECUADA PARA LA ADMINISTRACIÓN PARENTERAL, MEDIANTE INFUSIÓN PARA EL TRATAMIENTO DE CONDICIONES CARDÍACAS, ENVASADA EN UN RECIPIENTE SELLADO, Y QUE POSEE UN pH ENTRE 3,5 Y 6,5, Y MÉTODO PARA SU FABRICACIÓN
JP2012515221A5 (https=)
RU2009148985A (ru) Стабилизированные аморфные формы иматиниба мезилата
JP2011502968A5 (https=)
RU2007119724A (ru) Композиции, содержащие эктинэсайдин и дисахарид
JP2009545600A5 (https=)
CA2414063A1 (en) Highly concentrated stable meloxicam solutions
ECSP088240A (es) Composición de trazodona para administración una vez por día
JP2019536761A5 (https=)
ES2282062T1 (es) Composicion farmaceutica que contiene irbesartan.
JP2025163108A5 (https=)
RU2012113844A (ru) Пероральные суспензионные лекарственные формы ацетата эсликарбазепина
JP2013505233A5 (https=)
JP2011506587A5 (https=)
JP2009521473A5 (https=)
CN1829503B (zh) 含有氟苯尼考的兽用水性可注射悬浮液
JP2009511590A5 (https=)
RU2012112839A (ru) Новая парентеральная композиция карбамазепина
HRP20241424T1 (hr) Pripravak koji sadrži ramipril i indapamid